A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Johnson & Johnson stock. As of the latest transaction made, Citadel Advisors LLC holds 4,016,600 shares of JNJ stock, worth $586 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
4,016,600
Previous 2,646,100 51.79%
Holding current value
$586 Million
Previous $387 Million 68.31%
% of portfolio
0.13%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $116 Million - $133 Million
-797,335 Reduced 54.79%
657,796 $107 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $123 Million - $135 Million
853,507 Added 141.87%
1,455,131 $213 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $82.9 Million - $86.9 Million
533,850 Added 787.69%
601,624 $95.2 Million
Q4 2023

Feb 14, 2024

SELL
$145.6 - $158.88 $56.7 Million - $61.9 Million
-389,642 Reduced 85.18%
67,774 $10.6 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $276 Million - $310 Million
-1,774,854 Reduced 79.51%
457,416 $71.2 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $86 Million - $92.6 Million
557,451 Added 33.28%
2,232,270 $369 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $215 Million - $257 Million
1,424,288 Added 568.51%
1,674,819 $260 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $34.9 Million - $39.2 Million
218,146 Added 673.6%
250,531 $44.3 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $50.7 Million - $56.4 Million
-314,421 Reduced 90.66%
32,385 $5.29 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $123 Million - $136 Million
-731,210 Reduced 67.83%
346,806 $61.6 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $147 Million - $166 Million
926,572 Added 611.82%
1,078,016 $191 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $72.2 Million - $80.1 Million
-463,026 Reduced 75.35%
151,444 $25.9 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $17.3 Million - $19.3 Million
107,420 Added 21.19%
614,470 $99.2 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $53.6 Million - $57.5 Million
336,214 Added 196.81%
507,050 $83.5 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $161 Million - $179 Million
-1,049,897 Reduced 86.01%
170,836 $28.1 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $84.2 Million - $96.6 Million
613,815 Added 101.14%
1,220,733 $192 Million
Q3 2020

Nov 16, 2020

BUY
$140.38 - $153.83 $9.75 Million - $10.7 Million
69,458 Added 12.92%
606,918 $90.4 Million
Q2 2020

Aug 14, 2020

SELL
$128.81 - $155.51 $32.6 Million - $39.4 Million
-253,364 Reduced 32.04%
537,460 $75.6 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $278 Million - $385 Million
-2,498,735 Reduced 75.96%
790,824 $104 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $280 Million - $321 Million
2,192,485 Added 199.85%
3,289,559 $480 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $85.7 Million - $96 Million
675,207 Added 160.05%
1,097,074 $142 Million
Q2 2019

Aug 14, 2019

SELL
$131.15 - $144.24 $239 Million - $263 Million
-1,824,137 Reduced 81.22%
421,867 $58.8 Million
Q1 2019

May 15, 2019

BUY
$125.72 - $139.79 $182 Million - $203 Million
1,448,890 Added 181.77%
2,246,004 $0
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $72.2 Million - $86.9 Million
587,666 Added 280.58%
797,114 $103 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $19.8 Million - $23.2 Million
-162,572 Reduced 43.7%
209,448 $0
Q2 2018

Aug 10, 2018

SELL
$119.4 - $131.76 $59.1 Million - $65.2 Million
-495,056 Reduced 57.09%
372,020 $0
Q1 2018

May 11, 2018

SELL
$125.1 - $148.14 $9.31 Million - $11 Million
-74,418 Reduced 7.9%
867,076 $111 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $51.2 Million - $56 Million
389,810 Added 70.66%
941,494 $132 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $71.4 Million - $74.7 Million
551,684
551,684 $71.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.